Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.
CAFC Affirms Non-Infringement of Alnylam's LNP Delivery Patents by Moderna
cafc · 2025-06-04 · Defendant Win · Impact: 65/100
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc., decided by Federal Circuit on June 4, 2025, resulted in a defendant win outcome. The core dispute centered on whether Moderna's mRNA vaccine infringed o...